10 Oct 2018 - 10 Oct 2018
Alphabeta, Finsbury Square
John Carroll, Editor of Endpoints News, has invited our CEO, David Chiswell, to be on the panel of this summit, along with the likes of David Grainger (Medicxi) and Malcolm Weir (CEO, Heptares), and others.
The Golden Triangle in the UK is undergoing a major transformation as world-class scientific talent intermixes with a growing range of investors to create the next generation of drug developers in the UK. This October, Endpoints News will be bringing the biopharma community together for a special, half-day summit to address some of the most critical issues facing the country's drug development industry. And they'll be bringing together some of the top players in their fields to discuss financing, ROI and innovation and the exploding cancer drug development field.